Vetter is a leading contract development and manufacturing organization (CDMO) that specializes in the aseptic filling of syringes, cartridges and vials. The company has extensive experience with biologics and other complex compounds, including monoclonal antibodies, peptides, interferons and vaccines. Collaborating with pharma/biotech clients worldwide, Vetter supports products from preclinical development through global market supply. Through its US and European facilities, Vetter Development Service provides state-of-the-art support for early-stage products, with seamless transfer at Phase III to Vetter Commercial Manufacturing for large-scale production. The company offers state-of-the-art technology and innovative processes to promote product quality and maximize API yield.
Vetter Development Service aids clients in the development of drugs, from preclinical through to Phase III. From the outset, the product is developed with commercial production in mind, by using Vetter's manufacturing techniques. This enables the product to be easily taken to large-scale production by Vetter Commercial Manufacturing. Growing demand in the US for early-stage support has led to the establishment of the company's first US facility, based in Chicago.
Vetter Development Service provides:
Vetter Commercial Manufacturing offers Phase III clinical manufacturing services to companies worldwide. This service includes:
Supply chain security and integrity is maintained through regular quality reviews of upstream and downstream suppliers, and cross-linked IT systems to enable monitoring. Vetter provides commercial manufacturing services for the global top 10 biotechnology and pharmaceutical companies.
Vetter Packaging Solutions works with clients to find the best packaging solutions for their products. This can include a drug delivery system (primary packaging), cartoning / blister packaging (secondary packaging) and services such as pen-system assembly.
Vetter Packaging Solutions offers: